Essentially, in the presence of M2-TAMs, non-small cancer cells demonstrated an increased percentage of CD133+ cells accompanied with increased stemness and inflammation-associated genes including CD133, Sox2, and NF-κB. This evidence concerns the gene NFKB1 and cancer.